World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2017/02/007767
Date of registration: 03-02-2017
Prospective Registration: Yes
Primary sponsor: Mr Marc Alder
Public title: To check how intake of iron rich baby food can help in increasing the level of iron in blood and reduce the risk of iron deficiency.
Scientific title: Effectiveness of iron fortified infant cereals to increase the hemoglobin levels and to reduce the risk of iron-deficiency anemia in infants in India
Date of first enrolment: 20-03-2017
Target sample size: 160
Recruitment status: Completed
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=17088
Study type:  Interventional
Study design:  Other
Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
 
Phase:  N/A
Countries of recruitment
India
Contacts
Name: Dr Shariq Anwar   
Address:  6th Floor, Vatika Mindscape, 12/2 sector-27 D 121003 Faridabad, HARYANA India
Telephone: 8800799887
Email: sonika.newar@jssresearch.com
Affiliation:  JSS Medical Research India Private Limited
Name: Dr Sonika Newar   
Address:  6th Floor, Vatika Mindscape, Tower B,Plot 12/2 sector-27 D 121003 Faridabad, HARYANA India
Telephone: 8800799887
Email: sonika.newar@jssresearch.com
Affiliation:  JSS Medical Research India Private Limited
Key inclusion & exclusion criteria
Inclusion criteria: 1.Age at time of screening of Intervention group should be 6th month of life and Control group should be 12th month of life

2.Apparently healthy

3.Normal weight for age should be within greater or lesser than 2 SD of WHO growth curve

4.Breastfeeding (or formula feeding, or mixed feeding) is already complemented by other foods

5.Having obtained Parent or Legally Acceptable Representative Written Informed Consent


Exclusion criteria: Any of the following criteria would render a subject ineligible for inclusion:

1.Chronic illness necessitating medical follow up

2.Acute ongoing or recent (last 2 weeks) illness necessitating medical follow up

3.Parasitic infection

4.Currently enrolled in a fortification program

5.Documented intolerance to gluten

6.Documented intolerance to lactose

7.Documented allergy to bovine milk proteins

8.Infants with Hemoglobin < 100 g/L and CRP > 10 mg/L

9.Caregivers who are not likely to comply with the study procedures

10.Caregivers that plan to move to another area during the next 6 months (only for the intervention group)

11.Currently participating or having participated in another clinical study during the last 4 weeks prior to the beginning of this study.



Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Intervention(s)
Intervention1: Iron fortified infant cereal: 1. Fortified infant cereal, fortified with micronutrient and constituent with water
2. Daily two servings each of 25 gm of infant cereal reconstituted with 75 ml of lukewarm water in order to provide a puree consistency of cereal.
3. Duration is 6 month
4. Route of administration is oral.

Control Intervention1: NA: NA
Primary Outcome(s)
The iron status of infants, fed with iron fortified cereal, at 12 months of age will be higher or at least equal to that at baseline (6 months of age) or to that of the observational control group at 12 months of age.Timepoint: Baseline, 6 months age and 12 months age
Secondary Outcome(s)
To evaluate change in total body iron stores

To measure inflammatory status by evaluating C-Reactive protein (CRP)

To evaluate various hematological parameters

To access normal body development

To evaluate health status of study subjects for safety assessment during conduct of study

To assess dietary intake of subject

To study feeding pattern, parent satisfaction & cost of illness

To assess developmental status of subject

Timepoint: Baseline, 6 months age and 12 months age
Secondary ID(s)
15.11.INF; 1.0 dated 05 Aug 2016
Source(s) of Monetary Support
Mr. Marc Alder, Project Incharge, Nestec Ltd., Avenue Nestle 55, 1800 Vevey Switzerland
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 10/10/2016
Contact:
Institutional Ethics Committee King Goerge Hospital, Vishakhapatnam- 530002, Andhra Pradesh
Status: Approved
Approval date: 03/12/2016
Contact:
Institutional Ethics Committee Deccan College & Medical Sciences & Allied Hospital P.O. Kanchan Bagh DMRLX Road Santosh Nagar Hyderabad
Status: Approved
Approval date: 22/02/2017
Contact:
Institute of Child Hospital 11, Dr. Biresh Guha Street Kolkata-700017
Status: Approved
Approval date: 22/04/2017
Contact:
Institutional Ethics Committee King George Medical University, Office Research Cell, Administration Block King George Medical University, U.P. India
Results
Results available:
Date Posted:
Date Completed: 18/05/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history